Chemoinformaics analysis of 3,4-Dimethoxybenzyl alcohol
| Molecular Weight | 168.192 | nRot | 3 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 6 |
| Exact Molecular Weight | 168.079 | nRing | 1 |
| Solubility: LogS | -1.017 | nHRing | 0 |
| Solubility: LogP | 0.829 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 25.4375 |
| nHD | 1 | BPOL | 15.5105 |
| QED | 0.737 |
| Synth | 1.456 |
| Natural Product Likeliness | 0.375 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.192 |
| HIA | 0.004 |
| CACO-2 | -4.324 |
| MDCK | 0.0000225 |
| BBB | 0.856 |
| PPB | 0.390636 |
| VDSS | 0.99 |
| FU | 0.367486 |
| CYP1A2-inh | 0.768 |
| CYP1A2-sub | 0.871 |
| CYP2c19-inh | 0.164 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.705 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.912 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.477 |
| CL | 8.676 |
| T12 | 0.902 |
| hERG | 0.067 |
| Ames | 0.038 |
| ROA | 0.018 |
| SkinSen | 0.508 |
| Carcinogencity | 0.225 |
| EI | 0.96 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.057 |
| Antiviral | No |
| Prediction | 0.892409 |